Two mechanistically distinct effects of dihydropyridine nifedipine on CaV1.2 L-type Ca2+ channels revealed by Timothy syndrome mutation
详细信息查看全文 | 推荐本文 |
摘要
Dihydropyridine Ca2+ channel antagonists (DHPs) block CaV1.2 L-type Ca2+ channels (LTCCs) by stabilizing their voltage-dependent inactivation (VDI); however, it is still not clear how DHPs allosterically interact with the kinetically distinct (fast and slow) VDI. Thus, we analyzed the effect of a prototypical DHP, nifedipine on LTCCs with or without the Timothy syndrome mutation that resides in the I-II linker (LI-II) of CaV1.2 subunits and impairs VDI. Whole-cell Ba2+ currents mediated by rabbit CaV1.2 with or without the Timothy mutation (G436R) (analogous to the human G406R mutation) were analyzed in the presence and absence of nifedipine. In the absence of nifedipine, the mutation significantly impaired fast closed- and open-state VDI (CSI and OSI) at 鈭?#xA0;40 and 0 mV, respectively, but did not affect channels' kinetics at 鈭?#xA0;100 mV. Nifedipine equipotently blocked these channels at 鈭?#xA0;80 mV. In wild-type LTCCs, nifedipine promoted fast CSI and OSI at 鈭?#xA0;40 and 0 mV and promoted or stabilized slow CSI at 鈭?#xA0;40 and 鈭?#xA0;100 mV, respectively. In LTCCs with the mutation, nifedipine resumed the impaired fast CSI and OSI at 鈭?#xA0;40 and 0 mV, respectively, and had the same effect on slow CSI as in wild-type LTCCs. Therefore, nifedipine has two mechanistically distinct effects on LTCCs: the promotion of fast CSI/OSI caused by LI-II at potentials positive to the sub-threshold potential and the promotion or stabilization of slow CSI caused by different mechanisms at potentials negative to the sub-threshold potential.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700